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Abstract: Practical domestic monitoring of the menstrual 
cycle requires measurements of urinary metabolites of 
reproductive hormones: oestrone glucuronide (E1G) and 
pregnanediol glucuronide (PdG). Data reported in the 
literature are expressed as (i) concentration, without or 
with either creatinine- or specific gravity correction, or 
(ii) excretion rates. This variation in such a fundamental 
issue prompts consideration of the relationships between 
the four measures. Because the menstrual cycle kinetics 
of E1G and PdG are complex, we consider measurements 
of urinary creatinine, urea, galactose, xylose and inulin 
which tend to be more stable. We show that uncorrected 
concentration measurements of these urinary analytes 
can be positively correlated, negatively correlated or 
uncorrelated with the serum concentration. Based on 
measurements of urinary creatinine concentrations, 
urinary specific gravity and creatinine excretion rates, we 
conclude that urinary analyte concentration are likely to 
be more reliable when creatinine-corrected rather than 
corrected using specific gravity, but that both are less reli-
able than measurements of the excretion rate. This has 
implications for the quantitation of any urinary analyte, 
but especially for the monitoring of the menstrual cycle in 
which changes in E1G and PdG from one day to the next 
can be physiologically significant for a woman monitoring 
her fertility.
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1  Introduction
It is widely accepted that the menstrual cycle can be mon-
itored by following the serum concentrations of oestra-
diol (E2) and progesterone (P) [1]. However, there are 
several objections to this, of which two are of particular 
significance. First, the daily blood sampling required is 
unacceptable to women, so it is more usual to monitor 
the urinary metabolites of E2 and P instead [2]. The most 
common metabolites to be used in this way are, respec-
tively, oestrone 3-glucuronide (E1G) and pregnanediol glu-
curonide (PdG) [3-8]. Second, in monitoring the menstrual 
cycle what is actually relevant is the rate at which E2 and 
P are produced because that provides an insight into the 
dynamics of the process. For example, the rate of E2 secre-
tion increases with the diameter of the growing follicle 
and secretion ceases on ovulation, or shortly thereafter, 
and increases again as the corpus luteum develops. In this 
context the serum E2 concentration merely reflects the 
balance between E2 secretion and its speciation (into oes-
trone (E1) and oestriol (E3) and their various glucuronides 
and sulphonates) and excretion. The rate of excretion of 
E1G, for example, is more reliably related to the rate of E2 
secretion than it is to the E2 serum concentration [9].
While it is agreed that E1G and PdG are practical 
urinary analytes to monitor for this purpose, there is some 
debate about what should actually be measured. In prac-
tice, there are at least four common alternatives: (i) the 
analyte concentration [6, 7], (ii) concentration corrected 
by normalising to the creatinine concentration [10, 11], 
(iii) concentration corrected by normalising to the specific 
gravity [10, 11], or (iv) the analyte excretion rate [3, 4, 8]. 
On occasion, urinary analyte concentrations have been 
corrected by normalising to osmolality [12, 13], but this 
is not common among reports of E1G and PdG levels. For 
completeness, we note that mathematical approaches to 
correction have also been proposed[14-16] and many have 
tried to avoid the problem by using concentration ratios of 
urinary analytes including E1G and PdG [17-24]. 
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These measures have different requirements and tend 
to be used for slightly different purposes. Concentration is 
used to obtain an approximate indication of the events in 
the menstrual cycle. It is the basis of several widely used 
commercial tests that rely on measurements of reproduc-
tive hormones. It is claimed that women can use these 
as an aid in achieving or delaying pregnancy (we have 
recently reanalysed data on which some of these claims 
are based[25]). The creatinine-normalised concentra-
tion is used for more detailed comparisons of cycles and 
depends on laboratory-based measurements. The specific 
gravity-normalised concentration has often been used for 
epidemiological research and it also requires laboratory 
instruments. Measurements based on excretion rates can 
provide a woman with detailed information about her 
own cycle and she can carry them out in her own home 
[3-5, 26-28]. 
Given their significance to so many women and their 
partners, it is important to consider the limitations of 
these commonly used measures of E1G and PdG. However, 
even in a ‘normal’ menstrual cycle these analytes have 
very complex kinetics [8] because the events in the ovaries 
from which E2 and P come result from interactions with 
the pituitary gland involving other hormones (including 
luteinising and follicle-stimulating hormones). As there 
is nothing unique about the excretion of E1G and PdG we 
choose to clarify some of the issues associated with the 
various measures by considering analytes that have fewer 
of the complexities associated with the menstrual cycle. 
Specifically, we consider measures of urinary creatinine, 
inulin, xylose, galactose and urea for which data are 
available in the literature. Of these, creatinine is usually 
assumed to be excreted at a constant rate, inulin is con-
sidered metabolically inert and xylose is largely unmetab-
olised. We begin by defining the measures and examin-
ing the connections between them and considering the 
transfer of solutes from the blood to the urine. Then we 
use simple examples to clarify some of the issues associ-
ated with the use of these different measurements. While 
the approach we take arises from our work involving the 
metabolites of reproductive hormones, the treatment we 
outline (and our conclusions) are completely general. 
2  Theoretical background
2.1  Concentration
The urinary concentration of analyte A (uA) is just the 







(the corresponding serum concentration of A (sA) is 
defined similarly). Each of us knows from personal expe-
rience that the volume of urine (V) can fluctuate consid-
erably from void to void. Our own data indicate that the 
distribution of the volume of overnight urine samples 
tends to be positively skewed and ranges from about 50 
mL to approximately 1 L [29] and other data have a similar 
distribution, although V can have an even greater range 
(Brown, Cooke and Blackwell, manuscript in preparation) 
and if, as is often the case, circumstance dictates that 
daytime rather than overnight samples are sometimes col-
lected then the variation can be increased further. Based 
on our overnight data, two samples containing exactly the 
same quantity of an analyte can differ in concentration by 
about 20-fold just because of fluctuations in V [29]. The 
inevitable question is whether such a difference in uA has 
any physiological significance. In spite of these uncertain-
ties, reports of the use of concentration measurements to 
monitor reproductive hormones in urine are increasingly 
common and in some it is claimed that specific threshold 
values are associated with particular events in the cycle [2, 
6, 7, 30-46]. In none of these cases were the data of a single 
cycle used by a woman to monitor her own fertility. Our 
own data indicate that that physiological interpretation of 
a sequence of daily concentration-based measurements 
can be very challenging [9]. Instead, averaged cycles, 
usually based on data obtained from many women, were 
employed which prompts important questions some of 
which we will consider elsewhere (Cook, Blackwell and 
Brown, manuscript in preparaton).
2.2  Excretion rate
The excretion rate of analyte A (JA) is the quantity of A 
excreted per unit time. This is usually estimated as the 
amount accumulated in the volume of urine accumulated 
in the time since the previous void (Δt)
 (2)
It will be appreciated that JA can also be viewed as a func-
tion of both uA and the urine production rate ( ) 
A A VJ u J=  (3)
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We have shown that the distribution of JV of overnight 
urine samples tends to be positively skewed and ranges 
from about 10 mL h-1 to approximately 200 mL h-1 [29]. 
Based on these data, for two samples having exactly the 
same analyte concentration JA can vary about 20-fold 
just because of fluctuations in JV [29]. Despite this, it is 
not uncommon to find reports in which JV is assumed to 
be constant [47], uniformly distributed [48] or normally 
distributed [49]. For example, Karpas et al. [47] simply 
estimated uranium excretion rates by multiplying each 
urinary concentration by 1.4 L d-1 (3), which they assumed 
was the ‘population’ average JV.
2.3  Creatinine-corrected concentration
The urinary concentration of an analyte is often corrected 
using the concentration of creatinine (uCr) in the same 
urine sample. The most frequent approach is to divide uA
by uCr, although other creatinine corrections have been 
used for urinary analytes other than reproductive hor-
mones [50-52]. It will be appreciated from (1-4) that the 
simplest form of the creatinine-corrected concentration 
can be viewed interchangeably as a relative concentra-





= =  (5)
The concept of creatinine-correction is based on the work 
of Otto Folin [53-55] who analysed the 24 hour urines of 
institutionalised individuals kept on the same strict diet 
and fluid intake for several days. He observed “...the 
remarkable fact that the absolute quantity of kreatinin elim-
inated in the urine on a meat-free diet is a constant quantity 
different for different individuals, but wholly independent of 
quantitative changes in the total amount of nitrogen elimi-
nated. This appears ... to be another fixed principle in the 
chemistry of metabolism” [55: 84, his italics]. The widely 
held view that the rate of creatinine output (JCr = uCrJV) is 
constant is ultimately based on this, although Ohira et al.
[56] show how unreliable this generalisation can be. Nev-
erthless, it follows from this assumption that variations in 
uCr are inversely related to JV and that
 (6)
but the basis of the widespread use of this form of creati-
nine correction neglects Folin’s observation that JCr is “ .. 
a constant quantity different for different individuals” on a 
meat-free diet [55 p. 84, our italics]. Not only does the JCr
differ between subjects, but it can also vary considerably 
for a single subject. For example, JCr depends on diet [57], 
exercise, age, muscle mass and BMI [58, 59], and there is 
some evidence that it varies diurnally [60, 61] and during 
the course of the menstrual cycle [62-71].
Creatinine correction is very widely used for various 
urinary analytes and it is often suggested that urine 
samples that are too dilute (uCr < 0.5 g/L) or too concen-
trated (uCr > 3 g/L) should be discarded [72], although other 
limits are sometimes used [56, 73, 74]. Such samples are 
not uncommon, for example, Gaines et al. [75] report that 
43 or 29 of 417 samples (a total of 17%) were too dilute (uCr
< 0.5 g/L) or too concentrated (uCr > 3 g/L), respectively. For 
data we have previously reported [76], 13% of samples pro-
vided by 12 women over 26 menstrual cycles would have 
been excluded from further consideration on this basis. 
To put this in context, a woman monitoring her menstrual 
cycle might expect to exclude one of her daily samples 
each week just because uCr is not within the range. As 
women rely on such measurements to provide informa-
tion on which they base potentially significant decisions, 
this is not desirable. However, the main practical problem 
with this mode of correction in monitoring the menstrual 
cycle is that it requires that creatinine is assayed in addi-
tion to E1G and PdG, a combination that has not yet been 
established for home use. Nevertheless, it is likely that 
this approach will be tried and so we include some con-
sideration of creatinine correction below (see section 5.5, 
particularly).
2.4  Specific gravity-corrected concentration
An alternative means of correcting uA is usually described 
as being based on the specific gravity (SG) of the urine. 
In practice, SG is usually estimated using a refractome-
ter rather than a hydrometer [10] because there is a good 
correlation between the SG and refractive index of urine 
[77]. This correction has been implemented in various 
ways, but in each case the concentration is normalised to 
a function of the specific gravity (f(SG)) of the urine. One 
common form of the specific gravity-corrected concentra-
tion is 
 (7)
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where SGreference = 1.020 for Australian or US samples [10, 
11], 1.015 for Bangladeshi samples [10] and other values 
are sometimes used [78]. It is often suggested that samples 
that are too dilute (SGsample < 1.010) or too concentrated 
(SG sample > 1.030) should be discarded [72], although this 
is not always done [11] and other limits are sometimes 
used [74]. For example, Gaines et al. [75] reported that 63 
or 9 of 417 samples (17%) were too dilute (SG < 1.010) or 
concentrated (SG > 1.030), respectively (it is clear from 
the distributions reported by these authors that not all of 
these samples were also excluded based on uCr). Strongly 
nonlinear relationships between (i) uA corrected by SG and 
that corrected by uCr [79-82] and (ii) uCr and SG [52, 75, 78] 
are often reported. Perhaps of even more relevance, it has 
been reported that SG-based estimates of JV can be very 
unreliable [83].
3  The connection between blood 
and urine
The fluid and solutes present in urine are derived from the 
blood by filtration through the glomeruli in the kidneys. 
Two simple conservation relations relating to this were 
first formulated by Rehberg [84]. First, the volume con-
servation relation simply states that the volume of the 
blood filtered through the glomeruli (F) is matched by the 
total of the volumes of fluid that are reabsorbed (R) and 
excreted as urine (V) or
F V R= +  (8)
where, as Rehberg observed, R and F are much greater 
than V. Second, the material conservation relation just 
states that the quantity of analyte A filtered through the 
glomeruli (qA) matches that in the urine if A is not reab-
sorbed
A A Aq s F u V= =  (9)
where sA and uA are the concentrations of A in blood and 
urine, respectively. Combining (8) and (9) yields
 (10)
from which, since R can not be negative, it follows that uA
≥ sA, although uA is actually much greater than sA. 
Differentiating the material conservation relation (9), 
and using (1), gives the instantaneous excretion rate of A
A A A A
A A A
dq ds du du VdF dVj s F u V
dt dt dt dt dt dt
= = + = + =  (11)
However, the usual urinary measure is not instantane-
ous, because it takes a subject some time to accumulate 
sufficient urine to provide a sample. Instead, the urinary 
measure is the equivalent of the time average of the instan-
taneous excretion rate
 (12)
which is just JA (1-2). In (12), V(0) and uA(0) are, respec-
tively, the preceding post-void residual volume and the 
concentration of A in that volume which are impractical to 
measure for a woman monitoring her own fertility. As we 
have argued previously [9], the post-void residual volume 
is much smaller than the void volume providing that Δt
is sufficiently large. It is generally accepted that this is 
the case if Δt ≥ 3 hours [5, 85]. Even ignoring this approx-
imation, the practical reality is that a measurement of sA
reflects the situation at the time (and anatomical location) 
of sampling, whereas any urine measurement is averaged 
over the time (Δt) required to accumulate the volume of 
urine. 
As JA = < jA> rather than jA (12), it follows from (11) that
A A
A A A
ds dsdF dFJ s F s F
dt dt dt dt
= + = +   (13)






= +  (14)
This simply means that the time average of the instanta-
neous excretion rate (JA) is not the same as the instanta-
neous serum measurement (sAdF/dt) to which it is usually 
equated [86], especially if dsA/dt ≠ 0 which is usually the 
case for the reproductive hormones. In summary, the com-
bination of (11) and (12) gives
 (15)
where the approximation arises from the common 
assumption that it is legitimate to relate a time-averaged 
urine measurement (JA) to an instantaneous serum meas-
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urement (sA). In effect, the implicit assumption is that sA 
is a reasonable estimate of <sA>. Perhaps the most signif-
icant difference between (15) and the standard textbook 
expression [86] is that there is no assumption that dsA/dt 
= 0. Instead, as F > 0, (15) indicates that if dsA/dt averaged 
over Δt is not zero then the rate at which sA changes con-
tributes (positively or negatively) to JA. (Note that <FdsA/
dt> ≠ <F><dsA/dt> unless the covariance of F and dsA/dt 
happens to be zero.) This is entirely consistent with the 
common practice of infusing with an analyte when meas-
uring its clearance. In such circumstances (that is when 
dsA/dt = 0) the standard textbook expression [86] applies. 
Conversely, it implies that where dsA/dt ≠ 0, as is generally 
the case for reproductive hormones, this is not the case. 
4  Some implications 
The theory we have outlined has several implications 
of which we explicitly consider six that are of particular 
significance to the monitoring of urinary analytes. First, 
the relationship between uA and sA is likely to be incon-
sistent because it depends on F and V, both of which are 
functions of time. Second, the standard measure of JA is 
a time average of the instantaneous excretion rate (jA) 
which is particularly significant for some analytes. Third, 
it suggests that there is a linear relationship between JA 
and sA, if and only if dF/dt is approximately constant as 
is usually assumed in the measurement of clearance. 
Fourth, the relationship between JAand sA has an intercept 
that is proportional to the time-averaged value of FdsA/dt. 
Fifth, the equations (3, 6, 7) imply specific relationships 
between corrected uAand JV. We will consider the relation-
ship between the uncorrected uA and JV elsewhere (Brown, 
Cooke and Blackwell, manuscript in preparation) so this 
aspect of the theory is omitted. Sixth, the kinetics of sA and 
JA are not necessarily related in any simple manner which 
has particular relevance to the analysis of the menstrual 
cycle. We discuss several examples in section 5.
4.1  The relationship between uA and sA 
The material conservation relation (9) indicates that the 
urinary and serum concentrations of an analyte are not 
related in a simple manner. The relationship between uA 
and sA is positive, but inconsistent because it depends 
on F and V (9), both of which are functions of time. It is 
common knowledge that V changes depending on fluid 
intake, although there is a physiological limit to JV, but that 
there is little corresponding change in the blood [87, 88]. 
From this it follows that there is no good reason to expect 
a reasonable correlation between uA and sA for an individ-
ual subject, although good correlations have sometimes 
been reported for some analytes. It is the inconsistency 
in the correlation that is the fundamental problem: it is 
not possible to know when the correlation is reliable and 
when it is not. In effect, uA provides an unreliable means 
of estimating sA and if urinary analyte concentrations are 
monitored with that intention, as is sometimes the case in 
fertility monitoring, this should be made clear. 
4.2  The excretion rate (JA)
The standard measure of the excretion rate (JA, (2)) is a time 
average of the instantaneous excretion rate (jA). This tends 
to smooth the effects of both regular and sporadic fluctu-
ations of sA that would, in principle, be apparent in jA if it 
could be measured conveniently. For example, the serum 
concentration of each of several reproductive hormones 
is known to vary systematically on at least two different 
time scales. First, their concentrations exhibit pulsatility 
on a time scale that tends to be small compared with the 
widely accepted minimum Δt of 3 hours [89-101]. This 
means that while sA can depend significantly on where in 
the ‘cycle of pulsation’ the serum sample is obtained, JA 
is averaged over at least three hours, thereby providing 
a more reproducible measure by minimising the effects 
of the rapidly changing sA. Second, their concentrations 
vary systematically during the menstrual cycle [1, 8], 
rising or falling over several days (an important exception 
to this is luteinising hormone which usually rises very 
rapidly just before ovulation [102]). In such cases the time 
averaging over a few hours (Δt ≥ 3 hours) that is associated 
with measuring urinary metabolites does not present 
any significant problem (Cooke, Blackwell and Brown, 
manuscript in preparation).
In other cases, the impact of specific events can be 
more or less transitory. For example, after eating meat 
the serum creatinine concentration (sCr) can rise and fall 
over several hours [57] and this may recur at the next meal 
or not for several days. While assaying the rate of cre-
atinine excretion (JCr) does not eliminate this effect, the 
time averaging of jCr (12) reduces its amplitude to some 
extent. In contrast, deteriorating kidney function causes 
sCr to increase more slowly, over several months [103] or in 
transient cases it can rise or fall over days [104]. Similarly, 
some medications can increase sCr [105-107]. In all of these 
cases, the time averaging associated with the measure-
ment of JCr is not a technical limitation.
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4.3  The relationships between JA and sA (15)
The analysis indicates that there is a linear relationship 
between JA and sA (15) if the clearance (dF/dt) is constant 
as is usually assumed [86]. The same is not true of the rela-
tionship between JA and uA (Brown, Cooke and Blackwell, 
manuscript in preparation). This is unsurprising given the 
inconsistent relationship between uA and sA, but it is also 
consistent with the fact that JV, the time averaged value of 
dV/dt, is not constant in most circumstances and nor is 
dV/dt [29]. This means that sA is more reliably estimated 
using JA rather than uA, but, despite this, it should not be 
assumed automatically that dF/dt = uAV/sA because dsA/dt 
need not be zero (15).
4.4  Varying sA (dsA/dt)
The relationship between JA and sA has a non-zero inter-
cept that is proportional to dsA/dt. This means that (i) dF/
dt ≠ JA/sA unless dsA/dt = 0, consistent with the practice 
of ensuring this by infusion when measuring clearance, 
(ii) if dsA/dt varies systematically, as it does for the repro-
ductive hormones during the menstrual cycle, and this is 
not taken into account, there is systematic variation in 
the bias in the estimate of dF/dt or sA, and (iii) the corre-
lation between JA and sA can be good, but it need not be, 
and there is no reason to expect that it should be similar 
for several different experiments if dsA/dt is inconsistent 
(Appendix 1).
Analysis of the data from some reports yields estimates 
of <FdsA/dt> that are not statistically different from zero 
even if sA is not constant. We consider that this reflects the 
‘noise’ in the data because, as we show in section 5, high 
quality data obtained from experiments involving various 
analytes in which s A changes consistently yield values of 
the intercept consistent with (15). We infer from this that 
our interpretation of (15) is reasonable.
4.5  Creatinine and specific gravity correc-
tions of uA
Comparison of (6), (7) and (3) yields at least two obser-
vations. First, that in each expression uA is multiplied by 
a ‘correction factor’: JV, 1/uCr or f(SG) in (3), (6) and (7), 
respectively. Second, if each of these ‘corrected’ forms of 
uA is a potentially viable means of monitoring sA, then the 
three correction factors should be correlated in specific 
ways. That is, (i) JV should be inversely related to uCr, (ii) 
JV should be linearly related to f(SG) and (iii) f(SG) should 
be inversely related to uCr. As we show below (section 5), 
without correction uA is an unreliable means of monitoring 
sA. If any of these relationships ((3), (6) and (7)) is unsatis-
factory, then at least one of the ‘correction factors’ should 
be reconsidered. If any pair of relationships is unsatisfac-
tory, then it is likely that the common ‘correction factor’ 
is flawed.
4.6  The kinetics of sA and JA are not neces-
sarily simply related
During the menstrual cycle the levels of the reproductive 
hormones and their urinary metabolites change systemat-
ically, but they do not necessarily move perfectly in paral-
lel. For example, Monfort et al. [108] report correlations (r) 
between serum E2 and creatinine-corrected urinary oes-
trone conjugate (E1C) concentrations ranging from -0.176 
to +0.948 for 14 nonconceptive cycles. The mean correla-
tion coefficient was 0.596, similar to the mean values in 
some reports [10, 109-111], but lower than those in some 
others [112-114]. However, when Monfort et al. [108] intro-
duced a 24 h offset “to account for an approximately 24-h 
delay in excretion of urinary hormone metabolites”, the 
range became +0.465 to +0.945 (mean of +0.745). It will 
be apparent that this strategy does ‘improve’ the correla-
tions, but at least one of them remains unconvincing. 
In their analyses of short term experiments involv-
ing the ingestion or intravenous injection of various 
compounds, Dominguez and Pomerene [115] explic-
itly assumed that sA(t) = κjA(t), where t is time and κ > 0 
is a constant. This implies that sA and jA change in par-
allel and, specifically, reach maxima at the same time. 
However, it follows from the material conservation rela-
tion (9) that the maxima of sA and jA do not coincide in 
this way if the clearance (dF/dt) is constant (Appendix 2). 
Intuitively, it seems unlikely that the maxima might coin-
cide given that urine is derived from serum (section 3), 
implying differing kinetics. This is inconsistent with the 
assumption made by Dominguez and Pomerene [115], but 
it is consistent with the strategy employed by Monfort et 
al. [108] and others [10, 111]. Note, however, that while this 
idea might be written as sA(t) = κuA(t – δ)/uCr(t – δ) ≈ κ′JA(t 
– δ), where δ is the ‘offset’, it is yet to be established that κ 
(or κ′) is constant rather than a function of dsA/dt as might 
be anticipated given (15). 
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5  Some experimental examples
During the menstrual cycle the serum concentrations of 
reproductive hormones rise and fall successively [5, 8], so 
dsA/dt changes from negative to positive and back during 
the cycle. To avoid this complexity, we consider data from 
experiments involving the excretion of exogenous creati-
nine [84, 116-119], urea [120, 121], inulin [122, 123], galac-
tose and xylose [124]. Where appropriate, we distinguish 
between general and analyte-specific observations using 
the subscripts A (sA, for example) and the relevant analyte 
(sCr, for example, in the case of creatinine), respectively. 
5.1  Decreasing sA (dsA/dt < 0) 
The rate of creatinine excretion (JCr) is approximately con-
stant for an individual on a meat-free diet, but the rate 
differs between individuals [55, 125-128]. As would be 
anticipated, sCr increases following creatinine ingestion 
and then decreases again with a rate constant of about 
0.17 h-1 as creatinine is excreted [118, 119, 129], consistent 
with the half lives reported by Chiou [130, 131]. The data 
indicate that it takes about 1-1.5 h to reach the maximum 
sCr after ingestion, although this can be greater if the dose 
is high [84, 116, 118, 119, 129, 132]. 
Rehberg [84, 116] carried out experiments on himself 
in which he ingested 5 g of creatinine in 200 mL of water 
and, starting about an hour later, periodically measured 
serum and urinary creatinine. He did not control his fluid 
or food intake and he carried on with his normal activi-
ties, so that there were considerable differences among 
the five experiments. The data show a monotonic decline 
in sCr that is consistent for all his experiments (Figure 
1A). Despite the relative lack of control of the conditions, 
all the data can be described using a single exponential 
decay for which the rate constant is k = 0.14 ± 0.01 h-1 (95% 
CI). While the observed decline in sCr is expected (Figure 
1A), there is no obvious pattern in the corresponding uCr 
data (Figure 1B). In contrast, JCr falls exponentially (Figure 
1C) and k = 0.15 ± 0.02 h-1 (95% CI), which is not signifi-
cantly different from that for the decline in sCr shown in 
Figure 1A (p = 0.221). Based on the difference in the pat-
terns of the data in Figure 1A and 2B, it is not unexpected 
that the correlation between uCr and sCr is not strong (r = 
0.497, p = 0.001, Figure 1D). In contrast, given that JCr and 
sCr decline similarly (Figure 1, A and C), it is unsurprising 
that there is a linear relationship between JCr and sCr (β0 = 
-89 ± 87 mg h-1 (95% CI), β1 = 9 ± 2 L h-1 (95% CI), r = 0.881, 
p < 0.001, Figure 1E). In this case the intercept is not signfi-
cantly different from zero (p = 0.053), but because dsCr/dt < 
0 (Figure 1A) β0 should be negative if (15) is correct. Based 
on these estimates, we infer from (15) that the creatinine 
clearance (dF/dt) was 9 L h-1 and <FdsCr/dt> ≈ -89 mg h-1 for 
Rehberg’s data. 
The fundamental features of Rehberg’s results are not 
peculiar to humans or to creatinine. Among many possible 
examples, Figure 2 is a summary of the results obtained 
from a single experiment in which galactose was injected 
into a dog at t = 0 h [133]. Both sgalactose and Jgalactose decline 
exponentially (Figures 2, A and C), but no consistent 
pattern is apparent for ugalactose (Figure 2B). It follows that 
there is no obvious relationship between ugalactose and sga-
lactose (Figure 2D), but there is a strong correlation between 
Jgalactose and sgalactose (Figure 2E). These data are reminiscent 
of Rehberg’s creatinine data (Figure 1) and similar canine 
data involving xylose [134] or creatinine [135]. Data from 
experiments involving rabbits injected with creatinine 
[136, 137] have been reported in less detail, but the rela-
tionship between JCr and sCr is just as clear.
It might be objected that these data were collected 
over just a few hours and might not be replicated over 
longer periods. However, Cope’s [117] data are consistent 
with those of Rehberg [84, 116], but his experiments were 
more carefully controlled. In 21 separate experiments 
Cope [117] ingested a varying quantity of creatinine (up 
to a maximum of 7 g) and measured J Cr between one and 
two hours after ingestion and sCr at the midpoint (one and 
a half hours after ingestion). Unlike Rehberg [84, 116], 
Cope refrained from fluid or food intake and was recum-
bent throughout each of the experiments. The latter factor 
is relevant because posture affects kidney function [138, 
139] and normal daily activities can affect the consist-
ency of the data obtained [120]. In Cope’s data, the rela-
tionship between uCr and sCr is clearly nonlinear (Figure 
3A), although it is positive (r = 0.916, p < 0.001) and is 
much clearer than that obtained by Rehberg (Figure 1D). 
However, a plot of JCr against sCr (15) has a slope (=dF/dt) 
of 12.7 ± 0.5 L h-1 (95% CI) and an intercept (= <FdsA/dt>) 
of -68 ± 20 mg h-1 (95% CI) and is clearly linear (r = 0.997, 
Figure 3B). As F > 0, the negative intercept is consistent 
with a declining sCr (dsCr/dt ≤ 0) at the time of measure-
ment (about 1.5 h after creatinine ingestion). While it is 
not possible to confirm this because Cope measured sCr 
only once in the course of each experiment, it is a reason-
able supposition based on Rehberg’s data (Figure 1A) and 
several reports of similar experiments [118, 119, 129, 132]. 
For completeness, we point out that Cope [117] plotted a 
form of Figure 3B and, without the benefit of (15), regarded 
the non-zero intercept as an unexplained artefact arising 
from the determination of plasma creatinine.
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Addis and Drury [120] carried out similar experiments 
on themselves using urea. They monitored their serum and 
urinary urea levels starting at least three hours after the 
ingestion of a unspecified range of quantities of the solid 
dissolved in a litre of water. Other than drinking 500 mL 
of water each hour there was no other food or fluid intake 
during the course of the measurements. They repeated 
this for 27 and 31 days, respectively, and Drury obtained 
the data shown in Figure 4. In this case, the slope is 5.9 ± 
0.2 L h-1 (95% CI) and the intercept is -0.1 ± 0.1 g h-1 (95% 
CI), which is significantly different from zero (p = 0.044). 
Based on (15), we infer that the clearance of urea (dF/dt) 
was 5.9 L h-1 and that <Fdsurea/dt> = -0.1 g h-1. For these data 
r = 0.997, but the corresponding data obtained by Addis 
are rather less convincing (r = 0.982), perhaps because he 
carried on with his normal activities during the experi-
ments, and one effect of this is that the intercept is not 
significantly different from zero (p = 0.380).
Intravenous injection of an analyte yields an essen-
tially instantaneous increase followed by a decline in sA, 
thereby eliminating any possibility of ambiguity about 
dsA/dt. One example of this involves the injection of inulin 
[122, 140, 141] which is a non-metabolisable oligosaccha-
ride [142]. The data of Ferguson and colleagues show that 
both the serum inulin concentration (sIn) and the inulin 
excretion rate (JIn) decline approximately exponentially 
after injection. For each subject JIn increases linearly with 
sIn (r = 0.988-0.999) and the intercept is negative [122]. 
These data are consistent with (15) given that ds In/dt < 0.
We have shown that the relationship between uA and 
sA can be negligible (Figures 1D and 2D) or positive (Figure 
3A), but even in laboratory conditions the relationship 
between uA and sA can be negative. For example, Shannon 
et al. [143] measured the excretion of xylose and creati-
nine. They show that as both sxylose and sCr decline, the 
corresponding urinary concentrations actually increase 
(Figure 5, A and C) because the data are confounded by a 
corresponding decline in JV. In contrast, Jxylose and JCr both 
increase linearly with their respective serum concentra-
tions (Figure 5, A and C) because JV is taken into account 
(15). 
Figure 1: The (A) serum (sCr) or (B) urine creatinine concentration 
(uCr), (C) the creatinine excretion rate (JCr) observed following the 
ingestion of various quantities of creatinine, and the relationships 
between uCr (D)  or JCr (E) and sCr  The curves in (A) and (C) are single 
exponential functions fitted by nonlinear least squares for which 
the rate constants (k) are 0.13 ± 0.02 h-1 (95% CI) and 0.17 ± 0.04 
h-1 (95% CI), respectively, which are not significantly different (p = 
0.221).  In (E) the line is the least squares fit to the data (r = 0.881) 
and the slope (β1 = 9 ± 2 L h-1 [95% CI]) is significantly different from 
zero (p < 0.001), but the intercept (β0 = -0.09 ± 0.09 g h-1 [95% CI]) 
is not (p = 0.057).  The data are those reported by Rehberg [84, 116] 
for a series of experiments he carried out on himself.  Note that the 
outlier (▴) was omitted from the analysis in (A), (C) and (E).
Figure 2.  The (A) serum (sgalactose) or (B) urine galactose concentration 
(ugalactose), (C) the galactose excretion rate (Jgalactose) observed following 
the injection of galactose, and the relationships between ugalactose (D)  
or Jgalactose (E) and sgalactose  The curves in (A) and (C) are single expo-
nential functions fitted by nonlinear least squares for which the rate 
constants (k) are 0.75 ± 0.04 h-1 (95% CI) and 0.71 ± 0.05 h-1 (95% CI), 
respectively, which are not significantly different (p = 0.156).  In (E) 
the line is the least squares fit to the data (r = 0.999) and both the 
slope (β1 = 2.83 ± 0.09 L h-1 [95% CI]) and the intercept (β0 = -0.2 ± 
0.1 g h-1 [95% CI]) are significantly different from zero (p ≤ 0.012).  
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5.2  Constant sA (dsA/dt = 0)
In experiments in which a single bolus of a compound is 
ingested or injected, the serum concentration rises rapidly 
and then falls, but sA is roughly constant (dsA/dt = 0) for 
only a brief period. The time during which dsA/dt = 0 can 
be prolonged by infusing a compound continuously or, in 
some circumstances, if the subject refrains from consum-
ing any of that compound prior to and during the moni-
toring period. 
It is standard practice to infuse continuously with 
inulin when measuring glomerular filtration rate and, 
in these circumstances, sIn can be maintained at approx-
imately constant specific values (so that dsIn/dt ≈ 0). In 
such experiments, consistent with (15), JIn depends line-
arly on sIn and the intercept (FdsIn/dt) is not significantly 
different from zero. For example, Kennedy et al. [123] 
carried out inulin infusion experiments on 14 subjects, 
for each of whom several different sIn were maintained. 
Their data indicate that the intercept of JIn versus sIn was 
not significantly different from zero for any of the subjects 
[123], consistent with dsIn/dt = 0 at each sampling time. 
Shannon and Smith [144] show similar data for a further 
four subjects. The intercept was not significantly different 
from zero for any of them (p ≥ 0.112, based on our digitisa-
tion of their data).
5.3  Increasing sA (dsA/dt > 0)
Equation (15) indicates that the intercept of JA versus sA 
should be positive when sA increases throughout the 
experiment (dsA/dt > 0). One report of experiments in 
which sA is continuously increased while both blood 
and urine samples are collected is that of Drury [121]. He 
reported experiments in which dogs were infused con-
tinuously with urea at rates exceeding the urea excretion 
rate (Jurea). This resulted in a continuous increase in the 
serum urea concentration (surea) in samples collected over 
several hours. These data show that as surea increased, 
uurea increased (r = 0.967; Figure 6A), decreased (r = -0.597; 
Figure 6B) or was approximately constant (r = -0.051; 
Figure 6C). In every case, Jurea  increased linearly with surea 
(Figure 6, D-F) and the correlation coefficient (r) ranged 
from 0.952 to 0.991. In all cases except one (Figure 6E) the 
intercept was positive, consistent with dsurea/dt > 0 (15), 
although in the single exception the intercept was signifi-
Figure 3:  Relation between serum creatinine concentration (sCr) and 
(A) the urinary creatinine concentration (uCr) or (B) the creatinine 
excretion rate (JCr) observed following the ingestion of various 
quantities of creatinine.  In (B) the line is the least squares fit to the 
data (r = 0.997) and each parameter  (β1 = 12.7 ± 0.5 L h-1 [95% CI], 
β0 = -0.07 ± 0.02 g h-1 [95% CI]) is significantly different from zero 
(p < 0.001).  The data are those reported by Cope [117] for a series of 
experiments he carried out on himself.
Figure 4: Relation between serum urea concentration (surea) and the 
rate of urea excretion (Jurea) for a series of urea ingestion experiments 
carried out on a single human subject [120].  The line is the least 
squares fit to the data (r = 0.997) and each parameter (β1 = 5.9 ± 0.2 
L h-1 [95% CI], β0 = -0.1 ± 0.1 g h-1 [95% CI]) is significantly different 
from zero (p < 0.001 and p < 0.044, respectively).  A second subject 
carried out the same series of experiments but carried on with his 
daily activities (unlike the subject from whom the plotted data were 
obtained) and in that case r = 0.982, β1 = 4.4 ± 0.3 L h-1 [95% CI] 
and β0 = 0.1 ± 0.2 g h-1 [95% CI] but the intercept is not significantly 
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cantly different from zero (p = 0.012). This experiment pro-
vides a further support for (15).
The material conservation relation (9) indicates that 
the relationship between the urinary and serum concen-
trations of an analyte is not a simple one. Specifically, 
there is no good reason to assume that uA and sA are lin-
early related (Figures 1D and 2D, although they may be 
positively correlated. The results of Cope’s [117] creati-
nine ingestion experiments illustrate this point (Figure 
3A). However, (11) does lead to the prediction that the 
creatinine excretion rate (JA) is linearly related to sA (15), 
although the intercept does vary depending on the rate 
of change of sA. Again, Cope’s [117] data conform to this 
pattern (Figure 3B) in that it is likely that dsA/dt ≤ 0 in his 
experiment [118], although his data do not permit confir-
mation of this, and the estimate of FdsA/dt derived from 
his data is negative (Figure 3B). Cope’s [117] data provide 
clear justification for the use of the excretion rate (JA) 
rather than the urinary concentration (uA) to estimate sA 
even in very tightly controlled circumstances. In less well 
controlled experiments (Figures 1 and 2) and presumably 
in the lives of most women [145], there is even less justifi-
cation for relying on uA rather than JA.
5.4  Comparing uA and sA
It is clear from (15) that uA can be an unreliable means 
of monitoring sA (Figures 1D and 2D) because, while JA = 
uAJV is proportional to sA, JV  is not constant. The relation-
ship can be slightly more reliable if the data are collected 
in very tightly controlled conditions (as, for example, in 
Figure 3), because daily activities affect JV [120, 138, 139]. 
However, even in laboratory conditions, the relationship 
between uA and sA can be negative (Figure 5, A and C). 
In all of the examples we give, the corresponding corre-
lation between JA and sA is strongly positive (Figures 1E, 
2E, 3B, 5B and 5D). Equation (15) indicates that the critical 
difference is that JV is considered because JA = uAJV. The 
most significant problem for the use of uA in monitoring 
sA is inconsistency: while it may sometimes appear that uA 
relates linearly to sA , it takes relatively small fluctuations 
in JV to destroy the illusion and even if JV might be approx-
imately constant for given subject for some time, it would 
be unwise to expect that the same relationship applied to 
different subjects.
5.5  Comparison of uA correction factors
We have shown that sA is more reliably monitored using 
JA than uA in even the most controlled circumstances 
(Figures 1, 2 and 3). However, JA is merely uA corrected 
using JV (3), so it is reasonable to ask whether uA corrected 
using uCr (6) or f(SG) (7) might be just as useful. Viewed 
in this way, (i) uCr should depend hyperbolically on JV (3), 
(ii) f(SG) should be linearly related to JV (7) and (iii) uCr 
should depend hyperbolically on f(SG) ((6) and (7)). To 
test these predictions, we use the data based on 24 hour 
urine samples obtained over several days from subjects 
Figure 5.  Relation between the serum concentration of xylose (sxylose) 
or creatinine (sCr) and the corresponding urinary concentrations 
(uxylose (A) and uCr (C)) and excretion rates (Jxylose  (B) and JCr (D)) for an 
experiment carried out on a dog [143].  In each panel the line is the 
least squares fit to the data (r = -0.850 and -0.958 for (A) and (C), 
respectively, and r = 0.993 and 0.956 for (B) and (D), respectively).
Figure 6.  Relation between serum urea concentration (surea) and 
(A-C) urinary urea concentration (uurea) and (D-F) the urea excretion 
rate (Jurea) for three of the five experiments (each with a different 
rabbit) reported by Drury [121].  In each experiment the rate at which 
urea was infused exceeded Jurea so that dsurea/dt > 0.  In each panel 
the line is the least squares fit to the data (r = 0.967, -0.597 and 
-0.051 for (A), (B) and (C), respectively, and r = 0.989, 0.989 and 
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on a constant intake of fluid and food [53]. Folin reported 
uCr,V and SG, among other variables, and from these JV, JCr
and f(SG) can be calculated.
There is a clear inverse relationship between uCr and 
JV (Figure 7A) consistent with (3). However, as Folin [55] 
observed, despite all subjects having the same diet and 
fluid intake, JCr varied among the subjects. Sufficient data 
were available to estimate JCr for 33 subjects for whom the 
rates were approximately normally distributed (mean = 
1.2 ± 0.1 g/24 h, SD = 0.30 ± 0.07 g/24 h) and ranged from 
0.87 g/24 h to 1.51 g/24 h (the lower and upper bounds, 
respectively, of the shaded region in Figure 7A). It is appar-
ent from these data that uCr can change significantly with 
very small changes in JV (the open squares in Figure 7A) or 
change very little despite relatively large changes in JV (the 
open diamonds in Figure 7A). In these subjects JV ranged 
from 0.3 to 3.075 L/24 h (equivalent to 13-128 mL/h), which 
is more limited than the 10-200 mL/h we have reported for 
overnight urine samples from women free to eat and drink 
ad libitum [29].
The relationship between f(SG) and JV is not particu-
larly clear for the 44 of Folin’s [53] subjects for whom suf-
ficient data are available (Figure 7B). In some cases there 
is an essentially linear increase in f(SG) as JV increases, in 
other cases the relationship is nonlinear, but in five cases 
the relationship is negative so the correlation coefficient 
(r) ranges from -0.695 to 0.998. Overall, the slope (df(SG)/
dJV, which has units of h/L) is approximately normally dis-
tributed (mean = 0.4 ± 0.1 h/L, SD = 0.37 ± 0.08 h/L) and 
ranges from -0.69 to 1.27 h/L. 
The relationship between f(SG) and uCr is also some-
what unclear as is apparent from the inter-subject varia-
tion in the data shown in Figure 7C. Equations (6) and (7) 
imply that f(SG) declines hyperbolically with increasing 
uCr (f(SG) μ 1/uCr). However, rather than asymptotically 
approaching zero as uCr rises, f(SG) tends towards about 
0.6 (Figure 7C). This means that a slightly more suitable 
empirical relationship is , where 
α0 = 0.6 ± 0.5 (SD) and α1 = 0.6 ± 0.6 (SD) are approximately 
normally distributed for the 33 subjects for whom suffi-
cient data were reported [53] to permit their estimation. 
The uncertainties associated with these estimates are very 
large, consistent with the considerable inter-subject vari-
ation in the f(SG)-uCr relationship. Neverthless, the value 
of α0 is consistent with the normal range of urinary SG, 
which is 1.008 to 1.030 [146], although values as low as 
1.001 and at least as high as 1.044 have been reported [146, 
147]. Nevertheless, f(1.030) = 0.67, which is not signifi-
cantly different from the asymptote estimated from Folin’s 
data (nor does the asymptote differ from f(1.044) = 0.45). 
6  Discussion
Changes in the serum concentration of an analyte (sA) can 
monitored by measuring the analyte or its metabolites in 
the urine. The most frequently used alternatives for meas-
uring urinary analytes are the concentration (uA, (2)), uA
corrected using either the creatinine concentration (uA/uCr, 
(6)) or specific gravity (uAf(SG), (7)), and the excretion rate 
(JA, (3)), which can be considered to be uA corrected using 
the urine production rate (JV). We have used simple exam-
ples as the basis for a consideration of the usefulness of 
these measures of urinary analytes. 
The analysis indicates that JA is linearly related to sA
providing that the clearance (dF/dt) is constant (15). As JA
is the product of uA and JV (3) and JV is not constant, there 
is no reason to expect that JA should necessarily be sys-
tematically related to uA. It follows that sA and uA are not 
necessarily related in any particular way either. The data 
show that JA depends linearly on sA (Figures 1E, 2E, 3B, 4B, 
4D, 5B, 5D, 6D-F), consistent with (15), whether dsA/dt is 
positive (Figure 3A), negative (Figure 4) or zero (Figure 6) 
as sA increases. In contrast, the corresponding values of 
uA show no apparent relationship (Figures 1D, 2D and 6C), 
or a positive (Figures 3A and 6A) or negative (Figures 5A, 
5C and 6B) correlation with sA. Certainly, the systematic 
decline of sA in Figures 1A and 2A is not apparent in the 
corresponding uA data (Figures 1B and 2B). This variability 
Figure 7.  Relation between (A) urinary creatinine concentration (uCr) 
and urine production rate (JV) and between f(SG) and JV (B) and uCr (C) 
for each of three different subjects (consistently identified in each 
panel: ●, ◊, □) maintained on a constant diet.  In each panel, the 
grey zones are concave hulls constructed around the all the availa-
ble data and are only intended to give an indication of the range of 
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of the uA-sA relationship is the essence of the problem in 
any analysis of the menstrual cycle based on uA: from one 
day to the next a change in uA might follow, diametrically 
oppose or be insensitive to changes in sA, and one can not 
tell which of these possibilities applies. It is the systematic 
changes in the levels of reproductive hormones that are 
the basis of any reliable analysis of the menstrual cycle 
[1, 5, 8]. We have shown or cited examples that demon-
strate that this is the case for at least creatinine, inulin, 
xylose, galactose and urea in humans, dogs and rabbits, 
but we anticipate that it also applies to other analytes and 
other species. The implication of the analysis, confirmed 
by these data, is that JA is a reliable means of monitoring 
sA, but uA is not. 
As JA can be seen as uAcorrected by JV, it is reasonable 
to ask whether JA differs in any material way from other 
corrected forms of uA: uA/uCr and uAf(SG). Equations (3), 
(6) and (7) imply that (i) uCr μ 1/JV, (ii) f(SG) μ JV and (iii) 
f(SG) μ 1/uCr. Only the first of these relationships (3) is 
unambiguously supported by creatinine excretion data 
obtained from hospitalised subjects on a constant meat-
free diet and exactly the same daily fluid intake [53]. Even 
in these data, however, JCr differs between subjects (Figure 
7A). The other two relationships involve f(SG) (Figure 7, B 
and C) and are much less convincing than that between 
uCr and JV (Figure 7A). One of the difficulties with f(SG) is 
that the range of urinary SG is limited [146] and so as uCr
increases f(SG) tends towards 0.6 (Figure 7C) rather than 
0. This means that f(SG) might be reasonably sensitive 
at low uCr, but is completely insensitive for uCr > 1.5 g/L 
(Figure 7C). As the normal range (10-90th percentiles) of 
uCr is 0.3354 to 2.372 g/L for north American subjects [148], 
we infer from this that f(SG) is likely to be essentially con-
stant for a significant proportion of ‘normal’ subjects for 
whom uCr is changing. In this respect, uA corrected using 
specific gravity (7) is likely to be less reliable than uA cor-
rected using uCr (6). This confirms what has been shown 
previously by various authors [52, 75, 78-82].
If JV and uCr are merely factors used to ‘correct’ uA and 
both vary between and within subjects, is there any sig-
nificant difference between them? Given (3) and (12), and 
recalling that E(Y)/E(X) = E(Y/X) + [1/E(X)]cov(Y/X, X) 
[149, 150], it follows that
 (16)
where cov(·, ·) is the covariance of the arguments. Recall-
ing that JCr =<jCr>= uCrJV and rearranging (16) yields
 (17)
which means that (5) applies if jCr is literally constant, in 
which case jCr = JCr and cov(jCr, jA/jCr) = 0, but otherwise 1/
uA may or may not be related consistently to JV. However, it 
is apparent from Folin’s [53] data (Figure 7) and the litera-
ture [60-71, 125-127, 151-157] that JCr is not literally constant. 
Given this, the pragmatic approach would be to assume 
that the relationship between the creatinine-corrected 
uA and JA is not consistent because it depends on jA and 
jCr (16), both of which may vary. The creatinine-corrected 
uA yields neither (i) a direct relationship with sA nor (ii) 
proportionality to JA unless JCr is constant, which seems 
unlikely in normal daily life [60-71, 125-127, 151-157].
In addition to the linear JA-sA relationship, (15) indi-
cates that there is second term that applies if sA is not con-
stant (dsA/dt ≠ 0). Specifically, (15) indicates that this term 
is negative, positive or zero if sA is decreasing, increasing 
or constant, respectively. We have shown that high quality 
data are often consistent with this simple interpretation 
(Figures 1-6). The significance of this term in (15) is that 
sA is probably rarely constant because of diet, exercise, 
damage to the kidney and very many other factors. For the 
reproductive hormones, which change systematically on 
several timescales, dsA/dt ≠ 0 for most of the menstrual 
cycle (an exception to this might be the P and PdG serum 
concentrations both of which are relatively constant from 
one day to the next during the follicular phase). 
It might seem to some readers that we have dealt at 
some length with something that is well understood. After 
all, in 1957 Wray [158: 529] observed that “[t]he practice of 
reporting pregnanediol outputs in mg per unit volume is 
contra-indicated by its great inaccuracy” and very similar 
comments were made a century earlier by Thudichum 
[159]. Despite this, the use of uA in the measurement of 
urinary metabolites of reproductive hormones continues 
[2, 6, 7, 30-46]. Moreover, there is still confusion in the 
literature about uA, JA and their link to JV. For example, 
JA and uA have been compared directly without regard to 
their dimensional incompatibility and practical differ-
ences [160, 161] and, perhaps even more confusing, data 
reported as uA/Δt have been described as excretion rates 
[162] or concentrations [36]. We have not searched exhaus-
tively for examples of this sort, but expect that there are 
more. We infer from this that while at least some of the 
theory we have outlined may be familiar, it is clearly not 
always understood.
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7  Conclusions
We draw two main conclusions from the theory and the 
supporting examples we have given. First, urinary analyte 
concentration (uA) does not provide a reliable estimate of 
either the serum analyte concentration (s A ) or the analyte 
excretion rate (JA). The commercial devices that purport to 
monitor fertility and/or the menstrual cycle by following 
the urinary metabolites of reproductive hormones (or the 
hormones themselves) are currently based on measure-
ments of uA [163, 164]. Substantiation of the claims made 
about at least some of these is based on questionable 
interpretations of the relevant data [25]. Women and their 
partners deserve better than the rough guess available to 
them at present. Second, the creatinine-corrected analyte 
concentration provides a better indication of changes in 
the serum analyte concentration than uA, but it can be 
unreliable if the rate of creatinine excretion is not con-
stant. The real problem is that it is not necessarily possible 
to distinguish those times when the method works well 
from those when it does not. The most reliable and useful 
measure of a urinary analyte is the excretion rate (JA).
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Appendix 1
It follows from (15) that if sA is falling (dsA/dt < 0) then 
J A < sAdF/dt and if sA is rising (dsA/dt > 0) then JA > sAdF/
dt. More generally, where (15) applies, JA should increase 
approximately linearly with sA, providing both the clear-
ance (dF/dt) and FdsA/dt are approximately constant. In 
these circumstances, the relationship should have a slope 
of dF/dt and an intercept of <FdsA/dt>. If (15) is fitted to 
the data by ordinary least squares regression, then the 
expected value of the slope is E(dF/dt) = rSJA/SsA [165] and 
that of the intercept is E(FdsA/dt) = <JA> – E(dF/dt)<sA>, 
where <x> and Sx and are the mean and standard devia-
tion of x, respectively, and r is the correlation coefficient 
between JA and sA. From this and (15)
(A1.1)
where CVx = Sx/<x>, which means that the correlation (r) 
between JA and sA will tend to be larger or smaller if dsA/
dt < 0 or dsA/dt > 0, respectively. Similarly, r will tend to 
increase (decrease) as SsA rises (falls) or as SJA falls (rises), 
so the ranges of variation of sA and JA determine whether 
there is or is not a statistically significant relationship 
between sA and JA. We accept that the least squares 
approach implies that the uncertainty in sA is negligible, 
but a similar, albeit more complex, result is obtained 
when this is not the case using Deming regression, for 
example. While the use of r in contexts such as this is dep-
recated for good theoretical reasons [166], it continues to 
be used and (A1.1) may account for some of the variability 
in the reported correlations between the serum concentra-
tion and urinary levels of reproductive hormones [10, 11, 
108, 110-114, 167] for which dsA/dt may be zero, positive 
or negative. Based on (15), the usual clearance expression 
(sAdF/dt = JA) [86] is correct only when dsA/dt = 0 (because 
F > 0). This is consistent with the standard practice in the 
measurement of clearance which is to ensure that dsA/dt
= 0 by infusing A [168, 169, p. 39-62]. It is not reasonable 
to assume that this is the case for reproductive hormones 
except, perhaps, for P in the follicular phase of the men-
strual cycle. Following ovulation, for example, serum E2 
falls and then both E2 and P transiently rise during the 
luteal phase of the cycle. 
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Appendix 2
The instantaneous excretion rate and sA can not both be 
maximal at the same time if the clearance (dF/dt) is con-
stant, which Dominguez and Pomerene [115, 118] assume. 
To see this recall from the material conservation relation 
(9), that the instantaneous excretion rate (jA) is
A A
A A
dq dsdFj s F
dt dt dt
= = +
    
                    (A2.1)




A 2 2 2 0
dj d s dsd F dFs F
dt dt dt dt dt
= + + =           (A2.2)
However, (i) if the clearance (dF/dt > 0) is constant, then 
d2F/dt2 = 0, and (ii) F > 0, so 
(A2.3)
when the instantaneous excretion rate is maximal. If sA is 
also maximal at this instant, then dsA/dt = 0 and d2sA/dt2
≠ 0, which is inconsistent with (A2.3). It follows that dsA/
dt ≠ 0 at the excretion rate maximum. 
